FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1997918706> ?p ?o ?g. }

• W1997918706 endingPage "799" @default.
• W1997918706 startingPage "793" @default.
• W1997918706 abstract "BackgroundElevated circulating levels of the protein galectin-3, a mediator of fibrogenesis, have previously been associated with adverse outcomes in heart failure (HF) patients and appear to modify response to certain pharmacologic therapies. This study investigated the relationship between galectin-3 level and clinical outcomes in HF patients randomized to implantable cardioverter defibrillator (ICD-only) or cardiac resynchronization therapy (CRT-D).Methods and ResultsPlasma galectin-3 concentrations were measured in 654 New York Heart Association functional class I/II patients participating in the MADIT-CRT trial. A heterogeneity of response was detected between pre-implantation galectin-3 and randomization group (CRT-D or ICD-only) on the primary MADIT-CRT trial end point of nonfatal HF event or death (P = .045). Among patients with baseline galectin-3 levels in the top quartile of the distribution, CRT-D was associated with a 65% reduction in risk of the primary end point (hazard ratio [HR] 0.35, 95% confidence interval [CI] 0.19–0.67), whereas among patients with lower baseline galectin-3 values CRT-D was associated with a 25% decrease in risk (HR 0.75, 95% CI. 0.51–1.11). Baseline galectin-3 level also was observed to be an independent predictor of the primary end point (multivariable adjusted HR per log unit increase: 1.55; 95% CI 1.01–2.38; P = .043).ConclusionsElevated galectin-3 was found to be an independent predictor of adverse HF outcome in patients with mildly symptomatic HF. A significant interaction of device randomization group with pre-implantation galectin-3 level was detected, with HF patients with the highest baseline galectin-3 levels deriving a disproportionately larger benefit from CRT-D." @default.
• W1997918706 created "2016-06-24" @default.
• W1997918706 creator A5010200052 @default.
• W1997918706 creator A5022012412 @default.
• W1997918706 creator A5038469190 @default.
• W1997918706 creator A5054830306 @default.
• W1997918706 creator A5067457088 @default.
• W1997918706 date "2014-11-01" @default.
• W1997918706 modified "2023-09-27" @default.
• W1997918706 title "Plasma Galectin-3 and Heart Failure Outcomes in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)" @default.
• W1997918706 cites W1943554866 @default.
• W1997918706 cites W1986750147 @default.
• W1997918706 cites W1986985376 @default.
• W1997918706 cites W2014189665 @default.
• W1997918706 cites W2015404118 @default.
• W1997918706 cites W2018049609 @default.
• W1997918706 cites W2020332328 @default.
• W1997918706 cites W2035667813 @default.
• W1997918706 cites W2050865773 @default.
• W1997918706 cites W2053101511 @default.
• W1997918706 cites W2067973515 @default.
• W1997918706 cites W2074958057 @default.
• W1997918706 cites W2075361978 @default.
• W1997918706 cites W2090048170 @default.
• W1997918706 cites W2098787760 @default.
• W1997918706 cites W2106421416 @default.
• W1997918706 cites W2123248199 @default.
• W1997918706 cites W2126617892 @default.
• W1997918706 cites W2130907431 @default.
• W1997918706 cites W2132715587 @default.
• W1997918706 cites W2134265214 @default.
• W1997918706 cites W2134996862 @default.
• W1997918706 cites W2135164569 @default.
• W1997918706 cites W2138605772 @default.
• W1997918706 cites W2141895646 @default.
• W1997918706 cites W2143795945 @default.
• W1997918706 cites W2144426613 @default.
• W1997918706 cites W2146521529 @default.
• W1997918706 cites W2148719028 @default.
• W1997918706 cites W2161321429 @default.
• W1997918706 cites W2166805849 @default.
• W1997918706 cites W2169401348 @default.
• W1997918706 cites W2172116519 @default.
• W1997918706 cites W2181968881 @default.
• W1997918706 cites W2328176404 @default.
• W1997918706 doi "https://doi.org/10.1016/j.cardfail.2014.07.018" @default.
• W1997918706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25106783" @default.
• W1997918706 hasPublicationYear "2014" @default.
• W1997918706 type Work @default.
• W1997918706 sameAs 1997918706 @default.
• W1997918706 citedByCount "36" @default.
• W1997918706 countsByYear W19979187062014 @default.
• W1997918706 countsByYear W19979187062015 @default.
• W1997918706 countsByYear W19979187062016 @default.
• W1997918706 countsByYear W19979187062017 @default.
• W1997918706 countsByYear W19979187062018 @default.
• W1997918706 countsByYear W19979187062019 @default.
• W1997918706 countsByYear W19979187062020 @default.
• W1997918706 countsByYear W19979187062021 @default.
• W1997918706 countsByYear W19979187062022 @default.
• W1997918706 countsByYear W19979187062023 @default.
• W1997918706 crossrefType "journal-article" @default.
• W1997918706 hasAuthorship W1997918706A5010200052 @default.
• W1997918706 hasAuthorship W1997918706A5022012412 @default.
• W1997918706 hasAuthorship W1997918706A5038469190 @default.
• W1997918706 hasAuthorship W1997918706A5054830306 @default.
• W1997918706 hasAuthorship W1997918706A5067457088 @default.
• W1997918706 hasBestOaLocation W19979187061 @default.
• W1997918706 hasConcept C126322002 @default.
• W1997918706 hasConcept C164705383 @default.
• W1997918706 hasConcept C168563851 @default.
• W1997918706 hasConcept C197934379 @default.
• W1997918706 hasConcept C203092338 @default.
• W1997918706 hasConcept C204243189 @default.
• W1997918706 hasConcept C207103383 @default.
• W1997918706 hasConcept C2776034619 @default.
• W1997918706 hasConcept C2777093960 @default.
• W1997918706 hasConcept C2778198053 @default.
• W1997918706 hasConcept C44249647 @default.
• W1997918706 hasConcept C68443243 @default.
• W1997918706 hasConcept C71924100 @default.
• W1997918706 hasConcept C78085059 @default.
• W1997918706 hasConceptScore W1997918706C126322002 @default.
• W1997918706 hasConceptScore W1997918706C164705383 @default.
• W1997918706 hasConceptScore W1997918706C168563851 @default.
• W1997918706 hasConceptScore W1997918706C197934379 @default.
• W1997918706 hasConceptScore W1997918706C203092338 @default.
• W1997918706 hasConceptScore W1997918706C204243189 @default.
• W1997918706 hasConceptScore W1997918706C207103383 @default.
• W1997918706 hasConceptScore W1997918706C2776034619 @default.
• W1997918706 hasConceptScore W1997918706C2777093960 @default.
• W1997918706 hasConceptScore W1997918706C2778198053 @default.
• W1997918706 hasConceptScore W1997918706C44249647 @default.
• W1997918706 hasConceptScore W1997918706C68443243 @default.
• W1997918706 hasConceptScore W1997918706C71924100 @default.
• W1997918706 hasConceptScore W1997918706C78085059 @default.
• W1997918706 hasIssue "11" @default.
• W1997918706 hasLocation W19979187061 @default.

• next